Tag: Becton, Dickinson & Co. (BD)
BD accelerates offerings with Bard
April 25, 2017HME News Staff
FRANKLIN LAKES, N.J., and MURRAY HILL, N.J. - Becton, Dickinson and Company will buy C. R. Bard for $24 billion, the companies announced April 23.
The deal builds on BD's position in medication management and infection prevention, and increases its opportunities in fast-growing clinical areas like vascular therapy, according to a press release.
"Combining with Bard will accelerate our ability to offer more comprehensive, clinically relevant solutions to customers and patients around the...
Becton, Dickinson & Co. (BD), Mergers & Acquisitions (M&A), Supplies
Sponsored Stories
SOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office
By John Koch, COO and co-founder, MediStreams